Ex Parte LaroseDownload PDFPatent Trial and Appeal BoardMay 4, 201814072466 (P.T.A.B. May. 4, 2018) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. 14/072,466 27569 7590 PAUL AND PAUL FILING DATE 11/05/2013 05/08/2018 1717 Arch Street Three Logan Square SUITE 3740 PHILADELPHIA, PA 19103 FIRST NAMED INVENTOR Robert Larose UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 2013-135 1017 EXAMINER BRANSON, DANIELL ART UNIT PAPER NUMBER 1616 NOTIFICATION DATE DELIVERY MODE 05/08/2018 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): INFO@PAULANDPAUL.COM claire@paulandpaul.com fpanna@paulandpaul.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte ROBERT LAROSE Appeal2017-006887 1 Application 14/072,466 Technology Center 1600 Before RICHARD M. LEBOVITZ, JOHN G. NEW, and TA WEN CHANG, Administrative Patent Judges. LEBOVITZ, Administrative Patent Judge. DECISION ON APPEAL This appeal involves claims directed to methods of preventing or killing post-harvest and/or storage disease pathogens on fruits and/or vegetables. The Examiner rejected the claims under 35 U.S.C. § 103(a) as obvious. We have jurisdiction under 35 U.S.C. § 6(b ). The rejection is affirmed. 1 The Appeal Brief ("Appeal Br.") identifies BioSafe Systems LLC, as the real-party-in-interest. Appeal Br. 1. Appeal2017-006887 Application 14/072,466 STATEMENT OF THE CASE Appellant appeals from the Examiner's final rejection of claims 11-15 under 35 U.S.C. § I03(a) as obvious in view of U.S. Patent Application Publication 2010/0119669 Al, published May 13, 2010 ("Ben Yehuda") in view of U.S. Patent Application Publication 2007/0179193 Al, published August 2, 2007 ("Takeuchi"). Appeal Br. 2. Claim 11, the only independent claim on appeal, reads as follows: 11. A method of preventing or killing post-harvest and/or storage disease pathogens on fruits and/or vegetables comprising contacting a fruit or vegetable with an effective amount of a composition consisting essentially of ( 1) hydrogen peroxide, an organic peroxide or a combination thereof; and (2) phosphorous acid, mono- and/or di-salts of phosphorous acid or a combination thereof. CLAIM INTERPRETATION Claim 11 is directed to a method of "preventing or killing post-harvest and/or storage disease pathogens on fruits and/or vegetables comprising contacting a fruit or vegetable with an effective amount of a composition." The composition is "consisting essentially of' two components: 1) hydrogen peroxide, an organic peroxide, or a combination of them; and 2) phosphorous acid, mono- and/ or di-salts of the acid, or a combination of them. We interpret the meaning of "consisting essentially of' as recited in claim 11. "Consisting essentially of' is a transition phrase commonly used to signal a partially open claim in a patent. Typically, "consisting essentially of' precedes a list of ingredients in a composition claim or a series of steps in a process claim. By 2 Appeal2017-006887 Application 14/072,466 using the term "consisting essentially of," the drafter signals that the invention necessarily includes the listed ingredients and is open to unlisted ingredients that do not materially affect the basic and novel properties of the invention. PPG Indus. v. Guardian Indus. Corp., 156 F.3d 1351, 1354 (Fed. Cir. 1998). Therefore, we must determine the "basic and novel properties" of the claimed invention. Appellants did not provide a definition or explanation in their Appeal Brief. However, the claim preamble states that the purpose of the composition is for "preventing or killing post-harvest and/or storage disease pathogens on fruits and/or vegetables." Therefore, it is reasonable to adopt this purpose as a basic and novel property of the composition. Consistently, the Specification states that "current phosphorus acid based products have a narrow spectrum of activity" and that "[ w ]hat is needed are compositions and methods that are broad spectrum in their activity and that are effective in protecting plants and crops from pathogenic infections and/or pre- and post-harvest pathogenic organisms which include bacteria and fungi." Spec. 2:12-18. Accordingly, we consider the ability of the combination of peroxide and phosphorous acid to protect crops from pathogens to constitute the basic and novel properties of the invention. Based on this determination, we conclude that the claim is open to unlisted ingredients that do not materially affect the ability of the composition to prevent or kill pathogens on fruits and vegetables. Moreover, even if the preventative or killing activity of the composition is diminished, the basic and novel properties of the claimed invention are not materially affected if the effect is not "of importance or consequence to those of ordinary skill in the art." PPG Industries, 156 F.3d at 1354. 3 Appeal2017-006887 Application 14/072,466 Finally, we note that the Specification states that "[t]he amount of hydrogen peroxide, an organic peroxide, or a combination can range from about 12 to about 18% by weight of the composition," that "[t]he amount of phosphorous acid, mono- and/or di-salts of phosphorous acid or a combination thereof can range from about 25 to about 30% by weight of the composition," and that "[t]he typical amount of the composition according to the invention that can be used in the methods described [in the Specification] can range from 1:2.5 dilution to about 1: 1000 dilution rate applied at from about 30 to about 100 gallons of spray solution per treated acre." Spec. 4:19--23, 5:3-6. Thus, the Specification suggests that a certain amount of variation in the amounts of the claimed ingredients used would not "materially affect" the basic and novel properties of the claimed invention. DISCUSSION The Examiner found that Ben Y ehuda describes or suggests a composition, as claimed, comprising hydrogen peroxide, potassium ions, and a pH regulator, which can be phosphorous acid. Final Act. 4. The Examiner found that Ben Y ehuda does not disclose an organic peroxide ( an alternative in claim 11 and recited specifically in claim 13), but found that Takeuchi describes a sterilization composition that includes an organic peroxide and a pH regulator. Id. Takeuchi teaches that its composition can be used for treatment of plants that are growing. Takeuchi ,r 50. The Examiner determined it would have been obvious to have utilized the organic peroxide described in Takeuchi in Ben Yehuda's composition "[b ]ased upon the teaching in Takeuchi et al. that an organic peroxide may .. . function as the source of peroxide in a composition that may be applied to plant products." Final Act. 5. 4 Appeal2017-006887 Application 14/072,466 Appellant contends that "both Ben Y ehuda and Takeuchi require additional components to be effective." Appeal Br. 5. Appellant states: "Ben Y ehuda requires at least one of the metals or metal ions of silver, copper or zinc. Further, Takeuchi requires an acrylimidazole as a precursor of the organic peroxide." Id. Appellant's argument does not persuade us that the Examiner erred. Contrary to Appellant's argument, Ben Yehuda does not require silver, copper, or zinc to be effective. In a preferred embodiment, Ben Y ehuda describes a composition comprising hydrogen peroxide, a "metal ion selected from the group consisting of copper, zinc, nickel, iron, manganese, molybdenum, potassium or combinations thereof', and optionally a pH regulator, which can be phosphorous acid. Ben Yehuda ,r,r 71-74, 78, 105. Thus, silver, copper, and zinc are among a list of choices that also includes potassium, which is required by dependent claim 14. See Final Act. 14. Appellant attempts to denigrate this broader teaching by stating that the abstract teaches inclusion of at least one of the three metals and all the examples contain silver. Reply Br. 2. However, "[i]t is well settled that a prior art reference is relevant for all that it teaches to those of ordinary skill in the art." In re Fritch, 972 F.2d 1260, 1264---65 (Fed. Cir. 1992). Thus, while there may be narrower teachings in Ben Y ehuda, we have not been given reason to ignore Ben Yehuda's broader teaching. Appellant contends that insoluble phosphates would form with silver, copper, and zinc, which would diminish the efficacy of the phosphorous acid. Appeal Br. 6. This argument is not supported by evidence or scientific reasoning, but is conclusory attorney argument. Appellant did not provide objective 5 Appeal2017-006887 Application 14/072,466 evidence that insoluble phosphates would form when following Ben Yehuda's teachings with respect to silver, copper, and zinc, and that such insoluble phosphates "would change the essential characteristics of the invention." Appeal Br. 6. An argument made by counsel in a brief does not substitute for evidence lacking in the record. Estee Lauder, Inc. v. L 'Orea!, S.A., 129 F.3d 588, 595 (Fed. Cir. 1997). Indeed, Appellant did not identify the "essential characteristics" of the claimed invention. As we defined it above in the claim interpretation section, even if the insoluble phosphate diminished the activity of the composition, such diminished activity would have to make the composition ineffective for preventing or killing the pathogens on the fruits and vegetables to an extent that is "of importance or consequence to those of ordinary skill in the art." Appellant has not established this fact nor made the argument that the composition would be ineffective to such a degree. In addition to this, even if insolubility were to occur when silver, cooper, or zinc are present, as discussed above, Ben Yehuda does not require their presence, rendering the argument moot. Appellant also asserts, without evidence or scientific reasoning, "one of ordinary skill in the art would expect ... [ silver, copper, or zinc] metal ions to catalyze the hydrolysis of an added acrylimidazole, [thereby] reducing the production of peroxycarboxylic acid, and the activity of the biocidal composition." Appeal Br. 6. Appellant also contends that presence ofN-acrylimidazole in Takeuchi would change the basic and novel properties of the claimed invention. Appeal Br. 6. 6 Appeal2017-006887 Application 14/072,466 Although Appellant did not specifically identify the claim number, this argument applies only to claim 13, which requires an organic peroxide. 2 Takeuchi teaches that N-acrylimidazole is mixed with hydrogen peroxide to produce an organic peroxide. Takeuchi ,r 12. Appellant states that N-acrylimidazole would: change the basic and novel character of the invention, because, as disclosed by Takeuchi, the acrylimidazole would react with the hydrogen peroxide to generate a preoxycarboxylic [ sic, peroxycarboxylic] acid, thus substituting another active species with necessarily different chemical and biological properties for the hydrogen peroxide. Appeal Br. 6. We do not find this argument to be persuasively supported. The N- acrylimidazole is used to produce an organic peroxide (i.e., peroxycarboxylic acid), which is specifically recited in all the rejected claims. Appellant did not provide adequate evidence that there is any N- acrylimidazole remaining after its reaction with hydrogen peroxide, or, if there is remaining N-acrylimidazole, that its presence would affect the ability of the composition to prevent or kill pathogens on fruits and vegetables. Reply Br. 2. Attorney argument is insufficient, absent objective evidence and/or adequate scientific reasoning. Consequently, any remaining N-acrylimidazole is not excluded by the claims. In the Reply Brief, Appellant argues that organic peroxide degrades, producing organic alcohol as a contaminant. Reply Br. 2. For this reason, Appellant states it would not have been substituted "for Ben Yehuda's 2 Claim 13. A method according to claim 11 wherein the composition comprises an organic peroxide [ sic, and?] a mono-salt of phosphorous acid and a di-salt of phosphorous acid. 7 Appeal2017-006887 Application 14/072,466 hydrogen peroxide, which Ben Yehuda touts as 'a well-known non-polluting oxidizing agent' (Paragraph [0029])." Id. Notwithstanding that this appears to be a new argument, which is not permitted in an Appeal Brief (3 7 C.F .R. § 4I.52(a)), Appellant did not establish, with adequate evidence, that an organic alcohol is produced when organic peroxide degrades, or that such an alcohol would been a deterrent to using organic peroxide in place of hydrogen peroxide. Appellant also appears to make another impermissible new argument in the Reply Brief: [T]here is nothing to suggest to one of ordinary skill in the art that Takeuchi's compositions would be "broad spectrum in their activity and that are effective in protecting plants and crops from pathogenic infections and/or pre- and post-harvest pathogenic organisms which include bacteria and fungi" (specification, page 2, lines 15-18). Reply Br. 2. Even if Appellant's argument had been timely, Appellant did not establish that the obvious combination of an organic peroxide and phosphorous acid would not have possessed broad spectrum activity or that such activity would have been unexpected. When a claimed product appears to be substantially identical to a product disclosed by the prior art, the burden is on the patent owner to prove that the product of the prior art does not necessarily or inherently possess characteristics or properties attributed to the claimed product. In re Best, 562 F.2d 1252, 1254-55 (CCPA 1977). Appellant has not met this burden on the record before us. The Examiner's decision to reject claims 11 is AFFIRMED. Dependent claims 12-15 were not argued separately and fall with claim 11. 37 C.F.R. § 4I.37(c)(l)(iv). 8 Appeal2017-006887 Application 14/072,466 TIME PERIOD No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(l )(iv). AFFIRMED 9 Copy with citationCopy as parenthetical citation